Market revenue in 2023 | USD 74.3 million |
Market revenue in 2030 | USD 175.9 million |
Growth rate | 13.1% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 51.95% in 2023. Horizon Databook has segmented the Mexico structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico structural heart devices market is projected for steady growth, fueled by a rising prevalence of CVDs like valvular heart disease and heart failure. This growing patient pool, coupled with an aging population, creates a significant demand for these technologies.
The competitive scene features a mix of established global players like Abbott, Edwards Lifesciences, and Medtronic battling for market share. In addition, domestic companies are emerging, aiming to capture a piece of the pie.
In Mexico, the competitive landscape is characterized by a strong presence of major players in the structural heart devices market, including Boston Scientific Corporation, Medtronic, Edwards Lifesciences Corporation, Abbott, Biomerics, Comed BV, LivaNova PLC, JenaValve Technology, Inc., and Cardio Kinetix 2.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into Mexico structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account